Handling & Disclaimer FOR RESEARCH USE ONLY
It removes common barriers such as travel, long wait times, and high costs associated with traditional healthcare visits
If you are borderline, your weight at the provider office matters
Bajaj, M.D., from LMC Diabetes and Endocrinology in Brampton, Ontario, Canada, and colleagues examined the efficacy and safety of retatrutide as a monotherapy in a 40-week phase 3 trial involving adults with type 2 diabetes inadequately controlled by diet and exercise alone
Eli Lilly's TRIUMPH Phase 3 program includes multiple trials across different populations: TRIUMPH-1: Obesity without type 2 diabetes (NCT05929066) TRIUMPH-4: Obesity with type 2 diabetes Additional trials: MASLD/NASH, cardiovascular outcomes, kidney outcomes What Trial Enrollment Includes Free study medication (retatrutide or placebo